The 68Ge/ 68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine?
- PMID: 17333177
- PMCID: PMC1914228
- DOI: 10.1007/s00259-007-0387-4
The 68Ge/ 68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine?
Comment on
-
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):982-93. doi: 10.1007/s00259-006-0317-x. Epub 2007 Jan 16. Eur J Nucl Med Mol Imaging. 2007. PMID: 17225119
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15653653', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15653653/'}]}
- Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, et al. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med 2005;46 Suppl 1:62S–6S. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s002590100502', 'is_inner': False, 'url': 'https://doi.org/10.1007/s002590100502'}, {'type': 'PubMed', 'value': '11585303', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11585303/'}]}
- Breeman WA, de Jong M, Kwekkeboom DJ, Valkema R, Bakker WH, Kooij PP, et al. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med 2001;28:1421–9. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s00259-003-1255-5', 'is_inner': False, 'url': 'https://doi.org/10.1007/s00259-003-1255-5'}, {'type': 'PubMed', 'value': '12937948', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12937948/'}]}
- Wild D, Schmitt JS, Ginj M, Macke HR, Bernard BF, Krenning E, et al. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. Eur J Nucl Med Mol Imaging 2003;30:1338–47. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s00259-004-1697-4', 'is_inner': False, 'url': 'https://doi.org/10.1007/s00259-004-1697-4'}, {'type': 'PubMed', 'value': '15551131', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15551131/'}]}
- Wild D, Macke HR, Waser B, Reubi JC, Ginj M, Rasch H. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur J Nucl Med Mol Imaging 2005;32:724. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s002590100639', 'is_inner': False, 'url': 'https://doi.org/10.1007/s002590100639'}, {'type': 'PubMed', 'value': '11734911', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11734911/'}]}
- Hofmann M, Maecke H, Borner R, Weckesser E, Schoffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001;28:1751–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources